Bank Of New York Mellon Corp Shattuck Labs, Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.96 - $3.26 $23,271 - $38,705	11,873 New	11,873 $27,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $4.59 $192,780 - $327,726	-71,400 Reduced 85.74%	11,873 $48,000
Q1 2022 May 11, 2022	SELL	$4.22 - $8.89 $1,688 - $3,556	-400 Reduced 0.48%	83,273 $354,000
Q4 2021 Feb 11, 2022	SELL	$8.36 - $21.08 $3,803 - $9,591	-455 Reduced 0.54%	83,673 $712,000
Q3 2021 Nov 12, 2021	BUY	$17.57 - $28.95 $245,277 - $404,142	13,960 Added 19.9%	84,128 $1.72 Million
Q2 2021 Aug 11, 2021	BUY	$24.14 - $37.68 $625,926 - $977,004	25,929 Added 58.61%	70,168 $2.03 Million
Q1 2021 May 13, 2021	SELL	$27.92 - $52.5 $6,812 - $12,810	-244 Reduced 0.55%	44,239 $1.29 Million
Q4 2020 Feb 09, 2021	BUY	$19.0 - $57.61 $845,177 - $2.56 Million	44,483 New	44,483 $2.33 Million

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $42.8M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.